Nebulized liposomal amphotericin prophylaxis in lung transplantation: shall we take it or leave it?
Open Access
- 30 May 2016
- journal article
- letter
- Published by Frontiers Media SA in Transplant International
- Vol. 29 (9) , 1053-1054
Abstract
Evaluation of the efficacy of prophylactic\ud nebulized amphotericin B lipid complex (nABLC) in lung transplantation at our University HospitaKeywords
This publication has 7 references indexed in Scilit:
- 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology ofAspergillusspp. infection in lung transplantationTransplant International, 2015
- Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant RecipientsAmerican Journal of Transplantation, 2006
- Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control StudyClinical Infectious Diseases, 2005
- AspergillusInfections in Transplant RecipientsClinical Microbiology Reviews, 2005
- Design of Aerosolized Amphotericin B Formulations for Prophylaxis Trials among Lung Transplant RecipientsClinical Infectious Diseases, 2004
- Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for managementThe Journal of Heart and Lung Transplantation, 2003
- Cytomegalovirus Infection Is a Risk Factor for Invasive Aspergillosis in Lung Transplant RecipientsClinical Infectious Diseases, 1998